
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Supplements and Featured Publications
about 26 years ago
Introduction: Missing the Target with Lipid-Lowering Therapyabout 26 years ago
Improving Cholesterol Control in Managed Care Populationsabout 26 years ago
Roundtable Discussion: Achieving More Aggressive LDL-C Loweringabout 26 years ago
Selected Abstracts


